Satellos Bioscience Inc. (MSLE) vs NeuroOne Medical Technologies Corporation (NMTC)

A side-by-side comparison of Satellos Bioscience Inc. and NeuroOne Medical Technologies Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MSLE vs NMTC

growth of $100 · dividends reinvested · last 1y
MSLE +13.7% (+13.7%/yr)NMTC -79.1% (-79.1%/yr)MSLE compounded faster over this window
Log scale — wide-divergence pair
101001kStart $100$114$21
MSLE NMTC

MSLE vs NMTC: by the numbers

  • •MSLE is the larger company ($10M vs $10M market cap).
  • •Both run net losses; MSLE's is the smaller (0.00% vs -71.51% net margin).

Metrics side by side

Valuation

MetricMSLENMTC
P/S ratioN/A0.96
P/B ratio0.172.54

Profitability

MetricMSLENMTC
Gross margin0.00%67.30%
Operating margin0.00%-34.94%
Net margin0.00%-71.51%
ROE-57.34%-189.76%
ROIC-59.35%-183.45%

Growth (annualized)

MetricMSLENMTC
Revenue CAGR (5Y)N/A37.21%
Total return CAGR (5Y)N/A-46.02%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.